한글목차

서맥 치료 기기 세계 시장 규모는 2024년에 92억 1,000만 달러로 평가되었고, 2030년에는 123억 8,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 5.03%를 보일 것으로 예측됩니다.

이러한 성장의 주요 요인은 심혈관 질환의 유병률 증가와 첨단 심박조율기 기술의 채택 증가에 기인합니다.

비정상적으로 느린 심박수를 특징으로 하는 서맥은 고령화 사회에서 점점 더 널리 퍼지고 있으며, 효과적인 치료 솔루션에 대한 수요 증가에 기여하고 있습니다. 이 시장은 무심실 인공심박조율기, MRI 지원 기기, 원격 모니터링 시스템 등의 기술 발전의 혜택을 누리고 있으며, 이는 모두 임상 결과를 개선하고 합병증 위험을 줄이기 위해 고안된 제품들입니다.

전기생리학 및 심장 리듬 관리 분야의 지속적인 기술 혁신은 서맥 치료 장치의 채택을 더욱 가속화하고 있습니다. 또한, 보험 환급 정책과 최소 침습 수술 기술의 발전으로 더 많은 환자들이 치료를 받을 수 있게 되었습니다.

헬스케어 투자 증가와 의료기기 제조업체와 연구기관의 전략적 제휴도 시장 확대에 중요한 역할을 하고 있습니다. 기술 발전과 조기 진단 및 조기 개입에 대한 인식이 높아지면서 수요를 더욱 촉진하고 있습니다.

인공지능(AI)이 심장 모니터링 시스템에 통합되면서 서맥을 감지하는 정확도가 크게 향상되어 적시에 치료할 수 있게 되었습니다. 배터리 수명이 길어지고 안전성이 강화된 무선 심박조율기가 널리 보급되고 있으며, 반복적인 수술의 필요성을 최소화하고 있습니다. 원격 환자 모니터링은 심장 건강 상태를 실시간으로 추적하여 보다 신속한 치료 조정을 가능하게 하는 원격 환자 모니터링이 점점 더 널리 보급되고 있습니다. 최소침습적 수술에 대한 선호는 혁신적인 심박조율기 이식 기술의 개발을 촉진하여 기존 수술의 일반적인 위험을 감소시키고 있습니다.

주요 시장 성장 촉진요인

심혈관 질환의 유병률 증가

주요 시장 이슈

인지도 저하와 과소진단

주요 시장 동향

임베디드 디바이스의 소형화 및 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(동서맥, 동정지, 동기능 부전 증후군, 빈맥-서맥 증후군, 하트 블록)
  • 기기별(Pacemakers, Defibrillator)
  • 최종사용자별(병원 및 진료소, 외래 진료 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 유형별
  • 디바이스별
  • 최종사용자별
  • 지역별

제5장 아시아태평양의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별
  • 디바이스별
  • 최종사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
  • 유형
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 남미의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 서맥 치료 기기 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제10장 시장 역학

• 성장 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제12장 세계의 서맥 치료 기기 시장 : SWOT 분석

제13장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology(Beijing) Co Ltd.
• Medico S.R.L.
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc.

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

영문목차

Global Bradycardia Treatment Devices Market devices was valued at USD 9.21 billion in 2024 and is projected to reach USD 12.38 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.03% during the forecast period. This growth is primarily driven by the increasing incidence of cardiovascular diseases and the rising adoption of advanced pacemaker technologies.

Bradycardia, characterized by an unusually slow heart rate, is increasingly prevalent among the aging population, contributing to a heightened demand for effective treatment solutions. The market is benefiting from technological advancements such as leadless pacemakers, MRI-compatible devices, and remote monitoring systems, all of which are designed to improve clinical outcomes and reduce the risk of complications.

Ongoing innovations in electrophysiology and cardiac rhythm management have further accelerated the adoption of bradycardia treatment devices. Additionally, supportive reimbursement policies and progress in minimally invasive surgical techniques have enhanced accessibility, prompting a greater number of patients to pursue treatment.

Increased healthcare investments and strategic collaborations between medical device manufacturers and research institutions are also playing a vital role in market expansion. Technological advancements, coupled with rising awareness about early diagnosis and intervention, are driving further demand.

The integration of artificial intelligence (AI) into cardiac monitoring systems has significantly enhanced the accuracy of bradycardia detection, facilitating timely treatment. Wireless pacemakers featuring extended battery life and enhanced safety profiles are gaining wider acceptance, minimizing the need for repeated surgical procedures. Remote patient monitoring is becoming increasingly prevalent, enabling real-time tracking of cardiac health and more responsive treatment adjustments. The preference for minimally invasive procedures has fostered the development of innovative pacemaker implantation techniques, reducing the risks typically associated with conventional surgeries.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing global burden of cardiovascular diseases (CVDs) is a major factor propelling growth in the bradycardia treatment devices market. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, accounting for approximately 17.9 million fatalities annually. This includes conditions such as heart failure, coronary artery disease, and arrhythmias, with bradycardia being a common manifestation.

The aging global population and increasingly sedentary lifestyles are contributing to a higher incidence of CVDs, expanding the potential patient base for bradycardia treatments. Enhanced diagnostic capabilities and growing awareness of heart-related conditions have empowered healthcare providers to detect and monitor bradycardia more effectively, leading to earlier interventions and greater demand for treatment devices.

Government initiatives and public health strategies aimed at combating cardiovascular diseases are further supporting the adoption of bradycardia treatment technologies. For instance, in Europe, 82% of CVD-related deaths in 2019 were attributed to heart attacks and strokes, highlighting the urgency for preventive care and timely intervention-areas where bradycardia treatment devices play a critical role.

Key Market Challenges

Limited Awareness and Underdiagnosis

A significant barrier to market growth is the limited awareness and underdiagnosis of bradycardia. Despite its potential health implications, the condition often goes unnoticed or is misdiagnosed due to its subtle or intermittent symptoms.

Many individuals with mild bradycardia may not exhibit noticeable signs such as dizziness, fatigue, or fainting, leading them to forgo medical consultation. This contributes to a large number of undiagnosed cases and delays in treatment. Additionally, some healthcare professionals may overlook the more nuanced symptoms of bradycardia, particularly when they occur sporadically, further contributing to underdiagnosis.

Early detection is essential for effective management and the prevention of complications. However, the lack of awareness-both among the general public and within the medical community-remains a critical challenge to the timely identification and treatment of the condition.

Key Market Trends

Miniaturization and Advancement of Implantable Devices

The miniaturization of devices and innovations in implantable technologies are transforming the bradycardia treatment landscape. These trends are central to the advancement of cardiac rhythm management and have significantly enhanced patient outcomes.

Modern pacemakers and implantable cardioverter-defibrillators (ICDs) are now substantially smaller and less obtrusive, making them easier to implant and more comfortable for patients. This reduction in device size contributes to less invasive procedures, faster recovery times, and decreased surgical risk-particularly beneficial for elderly patients or those with higher surgical risks.

Miniaturized devices have also expanded the range of patients eligible for implantation, including those with smaller anatomical structures. Implantable devices now feature advanced functionalities such as adaptive pacing algorithms and remote monitoring capabilities. These features enable healthcare providers to monitor patients' cardiac rhythms in real-time, allowing for timely adjustments and more personalized treatment plans.

Key Market Players

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology (Beijing)Co Ltd.
• Medico S.R.L.
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc

Report Scope:

In this report, the Global Bradycardia Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bradycardia Treatment Devices Market, By Type:

• Sinus Bradycardia
• Sinus Pause
• Sick Sinus Syndrome
• Tachy-brady Syndrome
• Heart Block

Bradycardia Treatment Devices Market, By Devices:

• Pacemakers
• Defibrillator

Bradycardia Treatment Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Bradycardia Treatment Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bradycardia Treatment Devices Market.

Available Customizations:

Global Bradycardia Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bradycardia Treatment Devices Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block)
  • 4.2.2. By Devices (Pacemakers{Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Devices
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Bradycardia Treatment Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Devices
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bradycardia Treatment Devices Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Devices
      • 5.3.1.2.3. By End User
  • 5.3.2. India Bradycardia Treatment Devices Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Devices
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Bradycardia Treatment Devices Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Devices
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Bradycardia Treatment Devices Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Devices
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Bradycardia Treatment Devices Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Devices
      • 5.3.5.2.3. By End User

6. Europe Bradycardia Treatment Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Devices
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bradycardia Treatment Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Devices
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Bradycardia Treatment Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Devices
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Bradycardia Treatment Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Devices
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Bradycardia Treatment Devices Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Devices
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Bradycardia Treatment Devices Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Devices
      • 6.3.5.2.3. By End User

7. North America Bradycardia Treatment Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type
  • 7.2.2. Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bradycardia Treatment Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Devices
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Bradycardia Treatment Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Devices
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Bradycardia Treatment Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Devices
      • 7.3.3.2.3. By End User

8. South America Bradycardia Treatment Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Devices
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bradycardia Treatment Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Devices
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Bradycardia Treatment Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Devices
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Bradycardia Treatment Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Devices
      • 8.3.3.2.3. By End User

9. Middle East and Africa Bradycardia Treatment Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Devices
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bradycardia Treatment Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Devices
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Bradycardia Treatment Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Devices
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Bradycardia Treatment Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Devices
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bradycardia Treatment Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Biotronik
• 14.3. Nihon Kohden Corporation
• 14.4. Lepu Medical Technology (Beijing)Co Ltd.
• 14.5. Medico S.R.L.
• 14.6. Oscor Inc
• 14.7. Osypka Medical Inc.
• 14.8. Microport Scientific Corporation
• 14.9. Boston Scientific Corporation
• 14.10.Medtronic Plc.

15. Strategic Recommendations

16. About Us & Disclaimer